- Home
- PBYI vs VFL Comparison
PBYI vs VFL Comparison
Compare PBYI & VFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- VFL
- Stock Information
- Founded
- PBYI 2010
- VFL 1993
- Country
- PBYI United States
- VFL United States
- Employees
- PBYI N/A
- VFL N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- VFL Finance/Investors Services
- Sector
- PBYI Health Care
- VFL Finance
- Exchange
- PBYI Nasdaq
- VFL Nasdaq
- Market Cap
- PBYI 126.5M
- VFL 131.4M
- IPO Year
- PBYI N/A
- VFL N/A
- Fundamental
- Price
- PBYI $2.42
- VFL $10.66
- Analyst Decision
- PBYI Strong Buy
- VFL
- Analyst Count
- PBYI 1
- VFL 0
- Target Price
- PBYI $7.00
- VFL N/A
- AVG Volume (30 Days)
- PBYI 524.8K
- VFL 38.0K
- Earning Date
- PBYI 11-07-2024
- VFL 01-01-0001
- Dividend Yield
- PBYI N/A
- VFL 4.16%
- EPS Growth
- PBYI 492.79
- VFL N/A
- EPS
- PBYI 0.47
- VFL N/A
- Revenue
- PBYI $243,569,000.00
- VFL N/A
- Revenue This Year
- PBYI N/A
- VFL N/A
- Revenue Next Year
- PBYI N/A
- VFL N/A
- P/E Ratio
- PBYI $5.20
- VFL N/A
- Revenue Growth
- PBYI 6.30
- VFL N/A
- 52 Week Low
- PBYI $2.23
- VFL $7.93
- 52 Week High
- PBYI $7.73
- VFL $10.77
- Technical
- Relative Strength Index (RSI)
- PBYI 36.08
- VFL 43.45
- Support Level
- PBYI $2.83
- VFL $10.62
- Resistance Level
- PBYI $3.25
- VFL $10.81
- Average True Range (ATR)
- PBYI 0.29
- VFL 0.12
- MACD
- PBYI -0.04
- VFL 0.02
- Stochastic Oscillator
- PBYI 6.03
- VFL 69.39
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About VFL abrdn National Municipal Income Fund
Delaware Investments Natl Muni Income is a closed-end investment fund. The Fund seeks to provide current income exempt from regular federal income tax consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, Delaware Funds by Macquarie Premier Models, Managed accounts, Closed-end funds, and Variable Insurance Products.